MDT Medtronic plc

  1. Stocks
  2. Healthcare
  3. NYSE: MDT

Price (delayed)

$126.70

Market cap

$170.8B

P/E Ratio

59.21

Dividend/share

$2.32

EPS

$2.14

Enterprise value

$196.05B

Sector: Healthcare
Industry: Medical Devices
Website: http://www.medtronic.com/

Highlights

The price to earnings (P/E) is 81% higher than the 5-year quarterly average of 32.8 and 60% higher than the last 4 quarters average of 36.9
The net income has contracted by 46% YoY and by 18% from the previous quarter

Key stats

What are the main financial stats of MDT
Market
Shares outstanding
1.35B
Market cap
$170.8B
Enterprise value
$196.05B
Valuations
Price to earnings (P/E)
59.21
Price to book (P/B)
3.36
Price to sales (P/S)
6.11
EV/EBIT
56.51
EV/EBITDA
31.83
EV/Sales
7.02
Earnings
Revenue
$27.93B
EBIT
$3.47B
EBITDA
$6.16B
Free cash flow
$4.63B
Per share
EPS
$2.14
Free cash flow per share
$3.44
Book value per share
$37.71
Revenue per share
$20.74
TBVPS
$27.4
Balance sheet
Total assets
$97.27B
Total liabilities
$46.34B
Debt
$30.32B
Equity
$50.76B
Working capital
$13.81B
Liquidity
Debt to equity
0.6
Current ratio
2.1
Quick ratio
1.58
Net debt/EBITDA
4.1
Margins
EBITDA margin
22.1%
Gross margin
63.9%
Net margin
10.4%
Operating margin
11.4%
Efficiency
Return on assets
3.1%
Return on equity
5.7%
Return on invested capital
7.6%
Return on capital employed
4.1%
Return on sales
12.4%
Dividend
Dividend yield
1.83%
DPS
$2.32
Payout ratio
108.4%

MDT stock price

How has the Medtronic stock price performed over time
Intraday
-0.47%
1 week
-3.22%
1 month
5.03%
1 year
28.06%
YTD
8.16%
QTD
7.25%

Financial performance

How have Medtronic's revenue and profit performed over time
Revenue
$27.93B
Gross profit
$17.83B
Operating income
$3.2B
Net income
$2.89B
Gross margin
63.9%
Net margin
10.4%
The operating income has shrunk by 50% YoY and by 10% QoQ
The net income has contracted by 46% YoY and by 18% from the previous quarter
The operating margin has declined by 45% year-on-year and by 11% since the previous quarter
MDT's net margin is down by 39% year-on-year and by 18% since the previous quarter

Growth

What is Medtronic's growth rate over time

Valuation

What is Medtronic stock price valuation
P/E
59.21
P/B
3.36
P/S
6.11
EV/EBIT
56.51
EV/EBITDA
31.83
EV/Sales
7.02
The price to earnings (P/E) is 81% higher than the 5-year quarterly average of 32.8 and 60% higher than the last 4 quarters average of 36.9
The EPS has declined by 46% year-on-year and by 19% since the previous quarter
The stock's price to book (P/B) is 34% more than its 5-year quarterly average of 2.5 and 24% more than its last 4 quarters average of 2.7
The company's equity fell by 2% YoY
MDT's P/S is 45% higher than its 5-year quarterly average of 4.2 and 25% higher than its last 4 quarters average of 4.9
Medtronic's revenue has decreased by 10% YoY

Efficiency

How efficient is Medtronic business performance
The company's return on invested capital has shrunk by 50% YoY and by 12% QoQ
MDT's return on assets is down by 47% year-on-year and by 18% since the previous quarter
Medtronic's return on equity has decreased by 46% YoY and by 19% QoQ
The return on sales has declined by 43% year-on-year and by 10% since the previous quarter

Dividends

What is MDT's dividend history
DPS
$2.32
Dividend yield
1.83%
Payout ratio
108.4%
Recent dividends

Financial health

How did Medtronic financials performed over time
The total assets is 110% greater than the total liabilities
The company's current ratio fell by 24% YoY and by 2.8% QoQ
Medtronic's quick ratio has decreased by 23% YoY and by 3.1% from the previous quarter
MDT's debt is 40% smaller than its equity
Medtronic's debt to equity has increased by 22% YoY
MDT's debt is up by 19% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.